1887
  1. الرئيسية
  2. A-Z Publications
  3. Qatar Medical Journal
  4. المجلد 2024, العدد 3
  5. المقالة
Volume 2024, Issue 3
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

ملخص

Background: Various prevalences of asthma in coronavirus disease 2019 (COVID-19) have been reported in different regions, and the association between asthma and COVID-19 subsequent mortality has been in debate. Thus, this study aimed to investigate whether there was a significant association between asthma and COVID-19 mortality in Spain through a meta-analysis.

Methods: The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were strictly complied with conducting this study. The pooled odds ratio (OR) with a corresponding 95% confidence interval (CI) was calculated by a random-effects model. The 2 statistics for heterogeneity, sensitivity analysis for robustness, Begg’s test, and Egger’s test for publication bias, along with subgroup analyses for confounding bias, were also performed to support the foundation of this study.

Results: The meta-analysis revealed that asthma was significantly associated with a lower risk of mortality among COVID-19 patients in Spain with a random-effects model (pooled OR = 0.78, 95% CI = 0.69–0.88, 2 = 35%). Further subgroup analyses by male proportion and sample size also indicated that a statistically significant negative correlation did exist between asthma and COVID-19 mortality. Robustness and no publication on-bias were evidenced by sensitivity analysis, Egger’s test, and Begg’s test, respectively.

Conclusion: In conclusion, patients with asthma were found to have a lower risk of mortality from COVID-19 in Spain, especially among elderly patients. In addition, asthmatic patients infected with COVID-19 may be at risk of death compared to non-asthmatic patients, which is not a cause for undue concern, thereby reducing the burden of medication.

© 2024 Shi, Han, Wang, Xu, Yang, Licensee HBKU Press.
Loading

جارٍ تحميل قياسات المقالة...

/content/journals/10.5339/qmj.2024.34
٢٠٢٤-٠٨-٠٦
٢٠٢٤-٠٩-٠٦
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2024/3/qmj.2024.34.html?itemId=/content/journals/10.5339/qmj.2024.34&mimeType=html&fmt=ahah

References

  1. World Health Organization. COVID-19 dashboard. https://covid19.who.int/. Accessed: September 10, 2023.
    [Google الباحث العلمي]
  2. Pal S, Gangu K, Garg I, Shuja H, Bobba A, Chourasia P, et al.. Gender and race-based health disparities in COVID-19 outcomes among hospitalized patients in the United States: A retrospective analysis of a national sample. Vaccines. 2022; 10:(12):2036. https://doi.org/10.3390/vaccines10122036
     [Google الباحث العلمي]
  3. Wang Y, Hao Y, Hu M, Wang Y, Yang H. Interstitial lung disease independently associated with higher risk for COVID-19 severity and mortality: A meta-analysis of adjusted effect estimates. Int Immunopharmacol. 2022; 111:109088https://doi.org/10.1016/j.intimp.2022.109088
     [Google الباحث العلمي]
  4. Al Kaabi N, Yang Y, Eldin Hussein S, Yang T, Abdalla J, Wang H, et al.. Efficacy and safety of a booster vaccination with two inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: Results of a double-blind, randomized, placebo-controlled, phase 3 trial in Abu Dhabi. Vaccines. 2023; 11:(2):299. https://doi.org/10.3390/vaccines11020299
     [Google الباحث العلمي]
  5. Calzetta L, Chetta A, Aiello M, Frizzelli A, Ora J, Melis E, et al.. The BNT162b2 mRNA COVID-19 vaccine increases the contractile sensitivity to histamine and parasympathetic activation in a human ex vivo model of severe eosinophilic asthma. Vaccines. 2023; 11:(2):282. https://doi.org/10.3390/vaccines11020282
     [Google الباحث العلمي]
  6. Shkalim Zemer V, Grossman Z, Cohen HA, Hoshen M, Gerstein M, Yosef N, et al.. Acceptance rates of COVID-19 vaccine highlight the need for targeted public health interventions. Vaccines. 2022; 10:(8). https://doi.org/10.3390/vaccines10081167
     [Google الباحث العلمي]
  7. Munoz X, Pilia F, Ojanguren I, Romero-Mesones C, Cruz MJ. Is asthma a risk factor for COVID-19? Are phenotypes important? ERJ Open Res. 2021; 7:(1):00216-2020. https://doi.org/10.1183/23120541.00216-2020
     [Google الباحث العلمي]
  8. Meghji J, Mortimer K, Agusti A, Allwood BW, Asher I, Bateman ED, et al.. Improving lung health in low-income and middle-income countries: From challenges to solutions. Lancet. 2021; 397:(10277):928–40. https://doi.org/10.1016/S0140-6736(21)00458-X
     [Google الباحث العلمي]
  9. Quirce S, Plaza V, Picado C, Vennera M, Casafont J. Prevalence of uncontrolled severe persistent asthma in pneumology and allergy hospital units in Spain. J Investig Allergol Clin Immunol. 2011; 21:(6):466–71.
    [Google الباحث العلمي]
  10. Vrotsou K, Rotaeche R, Mateo-Abad M, Machón M, Vergara I. Variables associated with COVID-19 severity: An observational study of non-paediatric confirmed cases from the general population of the Basque Country, Spain. BMJ Open. 2021; 11:(4):e049066. https://doi.org/10.1136/bmjopen-2021-049066
     [Google الباحث العلمي]
  11. Alvarez-Arroyo L, Carrera-Hueso FJ, El-Qutob D, Robustillo-Villarino M, Girona-Sanz AM, Pin-Godos MT, et al.. Descriptive study of a cohort of COVID-19 hospitalized patients in Spain. Gac Med Mex. 2021; 157:(1):76–83. https://doi.org/10.24875/GMM.M21000525
     [Google الباحث العلمي]
  12. Gude-Sampedro F, Fernández-Merino C, Ferreiro L, Lado-Baleato ó, Espasandín-Domínguez J, Hervada X, et al.. Development and validation of a prognostic model based on comorbidities to predict COVID-19 severity: A population-based study. Int J Epidemiol. 2021; 50:(1):64–74. https://doi.org/10.1093/ije/dyaa209
     [Google الباحث العلمي]
  13. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 2009; 6:(7):e1000100. https://doi.org/10.1371/journal.pmed.1000100
     [Google الباحث العلمي]
  14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ (Clin Res Ed). 2009; 339:b2535. https://doi.org/10.1136/bmj.b2535
     [Google الباحث العلمي]
  15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed). 2003; 327:(7414):557–60. https://doi.org/10.1136/bmj.327.7414.557
     [Google الباحث العلمي]
  16. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50:(4):1088–101.
    [Google الباحث العلمي]
  17. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed). 1997; 315:(7109):629–34. https://doi.org/10.1136/bmj.315.7109.629
     [Google الباحث العلمي]
  18. Arber N, Shah PL, Assoumou L, Rokx C, De Castro N, Bakhai A, et al.. Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19. Infect Dis Now. 2023; 53:(7):104760. https://doi.org/10.1016/j.idnow.2023.104760
     [Google الباحث العلمي]
  19. Belarte-Tornero LC, Valdivielso-Moré S, Vicente Elcano M, Solé-González E, Ruíz-Bustillo S, Calvo-Fernández A, et al.. Prognostic implications of chronic heart failure and utility of NT-proBNP levels in heart failure patients with SARS-CoV-2 infection. J Clin Med. 2021; 10:(2):323. https://doi.org/10.3390/jcm10020323
     [Google الباحث العلمي]
  20. Berenguer J, Ryan P, Rodríguez-Baño J, Jarrín I, Carratalà J, Pachón J, et al.. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect. 2020; 26:(11):1525–36. https://doi.org/10.1016/j.cmi.2020.07.024
     [Google الباحث العلمي]
  21. Calderón-Parra J, Cuervas-Mons V, Moreno-Torres V, Rubio-Rivas M, Blas PA, Pinilla-Llorente B, et al.. Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: Analysis of a nationwide registry. Int J Infect Dis. 2022; 116:51–8. https://doi.org/10.1016/j.ijid.2021.12.327
     [Google الباحث العلمي]
  22. Casas-Rojo JM, Ventura PS, Anton Santos JM, de Latierro AO, Arevalo-Lorido JC, Mauri M, et al.. Improving prediction of COVID-19 mortality using machine learning in the Spanish SEMI-COVID-19 registry. Int Emerg Med. 2023:1711–22. https://doi.org/10.1007/s11739-023-03338-0
     [Google الباحث العلمي]
  23. Castilla J, Guevara M, Miqueleiz A, Baigorria F, Ibero-Esparza C, Navascués A, et al.. Risk factors of infection, hospitalization and death from SARS-CoV-2: A population-based cohort study. J Clin Med. 2021; 10:(12):2608. https://doi.org/10.3390/jcm10122608
     [Google الباحث العلمي]
  24. Chamorro-de-Vega E, Rodriguez-Gonzalez CG, Manrique-Rodríguez S, Lobato-Matilla E, García-Moreno F, Olmedo M, et al.. Clinical course of severe patients with COVID-19 treated with tocilizumab: Report from a cohort study in Spain. Exp Rev Clin Pharmacol. 2021; 14:(2):249–60. https://doi.org/10.1080/17512433.2021.1875819
     [Google الباحث العلمي]
  25. Cisterna-García A, Guillén-Teruel A, Caracena M, Pérez E, Jiménez F, Francisco-Verdú FJ, et al.. A predictive model for hospitalization and survival to COVID-19 in a retrospective population-based study. Sci Rep. 2022; 12:(1):18126. https://doi.org/10.1038/s41598-022-22547-9
     [Google الباحث العلمي]
  26. de Arriba Fernandez A, Bilbao JLA, Frances AE, Mora AC, Perez AG, Barreiros MAD. Epidemiological study of vaccination against SARS-CoV-2 and its impact on COVID-19 progression in a cohort of patients in gran Canaria. Vacunas. 2023; 24:(4):308–16. https://doi.org/10.1016/j.vacun.2023.06.005
     [Google الباحث العلمي]
  27. Diaz MA, Catalan-Caceres N, Beauperthuy TC, Domingo C, Ibañez E, Morata C, et al.. Clinical features and outcomes associated with bronchial asthma among COVID-19 hospitalized patients. J Asthma Allergy. 2022; 15:775–81. https://doi.org/10.2147/JAA.S354082
     [Google الباحث العلمي]
  28. Fernández-Cruz A, Puyuelo A, Núñez Martín-Buitrago L, Sánchez-Chica E, Díaz-Pedroche C, Ayala R, et al.. Higher mortality of hospitalized haematologic patients with COVID-19 compared to non-haematologic is driven by thrombotic complications and development of ARDS: An age-matched cohorts study. Clin Infect Pract. 2022; 13:100137. https://doi.org/10.1016/j.clinpr.2022.100137
     [Google الباحث العلمي]
  29. Fernández-Martínez NF, Ortiz-González-Serna R, Serrano-Ortiz á, Rivera-Izquierdo M, Ruiz-Montero R, Pérez-Contreras M, et al.. Sex differences and predictors of in-hospital mortality among patients with COVID-19: Results from the ANCOHVID multicentre study. Int J Environ Res Public Health. 2021; 18:(17):9018. https://doi.org/10.3390/ijerph18179018
     [Google الباحث العلمي]
  30. Galindo-Andugar MA, Arias Arias A, Alfonso Garcia Guerra J, Fernandez Visier I, Manuel Fernandez Ibanez J, Bellido Maldonado A. Impact of N-acetylcysteine in the mortality of patients hospitalized with COVID-19: A retrospective cohort study. Rev Clín Esp. 2023; 223:(8):479–85. https://doi.org/10.1016/j.rceng.2023.07.006
     [Google الباحث العلمي]
  31. García de Guadiana-Romualdo L, Martínez Martínez M, Rodríguez Mulero MD, Esteban-Torrella P, Hernández Olivo M, Alcaraz García MJ, et al.. Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients. Int J Infect Dis. 2021; 111:211–8. https://doi.org/10.1016/j.ijid.2021.08.058
     [Google الباحث العلمي]
  32. Jiménez E, Fontán-Vela M, Valencia J, Fernandez-Jimenez I, álvaro-Alonso EA, Izquierdo-García E, et al.. Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: A retrospective case series study. BMJ Open. 2020; 10:(11):e042398. https://doi.org/10.1136/bmjopen-2020-042398
     [Google الباحث العلمي]
  33. Laosa O, Pedraza L, álvarez-Bustos A, Carnicero JA, Rodriguez-Artalejo F, Rodriguez-Mañas L. Rapid assessment at hospital admission of mortality risk from COVID-19: The role of functional status. J Am Med Dir Assoc. 2020; 21:(12):1798–802.e2. https://doi.org/10.1016/j.jamda.2020.10.002
     [Google الباحث العلمي]
  34. Lemus Calderon JA, Beneyto Martin P, Guzmán Rodriguez R, Caligaris Cataldi HS, Senent Sánchez CJ. Differentiating characteristics of patients with asthma in the severe acute respiratory syndrome coronavirus 2 infection. Ann Allergy Asthma Immunol. 2021; 126:(1):92–3. https://doi.org/10.1016/j.anai.2020.09.004
     [Google الباحث العلمي]
  35. Loucera C, Peña-Chilet M, Esteban-Medina M, Muñoyerro-Muñiz D, Villegas R, Lopez-Miranda J, et al.. Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients. Sci Rep. 2021; 11:(1):23380. https://doi.org/10.1038/s41598-021-02701-5
     [Google الباحث العلمي]
  36. Macias-Munoz L, Wijngaard R, Gonzalez-de la Presa B, Bedini JL, Morales-Ruiz M, Jimenez W. Value of clinical laboratory test for early prediction of mortality in patients with COVID-19: The BGM score. J Circ Biomark. 2021; 10:1–8. https://doi.org/10.33393/jcb.2021.2194
     [Google الباحث العلمي]
  37. Maestre-Muñiz MM, Arias á, Arias-González L, Angulo-Lara B, Lucendo AJ. Prognostic factors at admission for in-hospital mortality from COVID-19 infection in an older rural population in central Spain. J Clin Med. 2021; 10:(2):318. https://doi.org/10.3390/jcm10020318
     [Google الباحث العلمي]
  38. Martin-Vicente M, Almansa R, Martínez I, Tedim AP, Bustamante E, Tamayo L, et al.. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients. J Intern Med. 2022; 291:(2):232–40. https://doi.org/10.1111/joim.13386
     [Google الباحث العلمي]
  39. Martínez-Del Río J, Piqueras-Flores J, Nieto-Sandoval Martín de la Sierra P, Negreira-Caamaño M, águila-Gordo D, Mateo-Gómez C, et al.. Comparative analysis between the use of renin-angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection. Med Clin (Engl Ed). 2020; 155:(11):473–81. https://doi.org/10.1016/j.medcle.2020.07.013
     [Google الباحث العلمي]
  40. Martos Pérez F, Luque Del Pino J, Jiménez García N, Mora Ruiz E, Asencio Méndez C, García Jiménez JM, et al.. Comorbidity and prognostic factors on admission in a COVID-19 cohort of a general hospital. Rev Clín Esp. 2021; 221:(9):529–35. https://doi.org/10.1016/j.rceng.2020.05.010
     [Google الباحث العلمي]
  41. Mateos-Arroyo JA, Zaragoza-Garcia I, Sanchez-Gomez R, Posada-Moreno P, Ortuno-Soriano I. Validation of the Barthel index as a predictor of in-hospital mortality among COVID-19 patients. Healthcare (Basel). 2023; 11:(9):1338. https://doi.org/10.3390/healthcare11091338
     [Google الباحث العلمي]
  42. Molinero M, Benítez ID, González J, Gort-Paniello C, Moncusí-Moix A, Rodríguez-Jara F, et al.. Bronchial aspirate-based profiling identifies microRNA signatures associated with COVID-19 and fatal disease in critically ill patients. Front Med. 2021; 8:756517. https://doi.org/10.3389/fmed.2021.756517
     [Google الباحث العلمي]
  43. Oristrell J, Oliva JC, Subirana I, Casado E, Domínguez D, Toloba A, et al.. Association of calcitriol supplementation with reduced COVID-19 mortality in patients with chronic kidney disease: A population-based study. Biomedicines. 2021; 9:(5):509. https://doi.org/10.3390/biomedicines9050509
     [Google الباحث العلمي]
  44. Pavel AB, Glickman JW, Michels JR, Kim-Schulze S, Miller RL, Guttman-Yassky E. Th2/Th1 cytokine imbalance is associated with higher COVID-19 risk mortality. Front Genet. 2021; 12:706902. https://doi.org/10.3389/fgene.2021.706902
     [Google الباحث العلمي]
  45. Pérez-García F, Bailén R, Torres-Macho J, Fernández-Rodríguez A, Jiménez-Sousa M, Jiménez E, et al.. Age-adjusted endothelial activation and stress index for coronavirus disease 2019 at admission is a reliable predictor for 28-day mortality in hospitalized patients with coronavirus disease 2019. Front Med. 2021; 8:736028. https://doi.org/10.3389/fmed.2021.736028
     [Google الباحث العلمي]
  46. Rodríguez-Molinero A, Gálvez-Barrón C, Miñarro A, Macho O, López GF, Robles MT, et al.. Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients. PLoS One. 2020; 15:(10):e0239571. https://doi.org/10.1371/journal.pone.0239571
     [Google الباحث العلمي]
  47. Rubio-Rivas M, Ronda M, Padulles A, Mitjavila F, Riera-Mestre A, García-Forero C, et al.. Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness. Int J Infect Dis. 2020; 101:290–7. https://doi.org/10.1016/j.ijid.2020.09.1486
     [Google الباحث العلمي]
  48. Salgado-Barreira A, Seijas-Amigo J, Rodriguez-Manero M, Pineiro-Lamas M, Eiras S, Cordero A, et al.. Effect of dapagliflozin on COVID-19 infection and risk of hospitalization. J Antimicrob Chemother. 2023; 78:(9):2335–42. https://doi.org/10.1093/jac/dkad241
     [Google الباحث العلمي]
  49. Sarria-Landete AJ, Crespo-Matas JA, Dominguez-Quesada I, Castellanos-Monedero JJ, Marte-Acosta D, Arias-Arias AJ. Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection. Med Clin (Engl Ed). 2022; 159:(12):557–62. https://doi.org/10.1016/j.medcle.2022.02.028
     [Google الباحث العلمي]
  50. Torres-Macho J, Ryan P, Valencia J, Perez-Butragueno M, Jimenez E, Fontan-Vela M, et al.. The PANDEMYC score. An easily applicable and interpretable model for predicting ortality associated with COVID-19. J Clinical Med. 2020; 9:(10):3066. https://doi.org/10.3390/jcm9103066
     [Google الباحث العلمي]
  51. Valverde-Monge M, Canas JA, Barroso B, Betancor D, Ortega-Martin L, Gomez-Lopez A, et al.. Eosinophils and chronic respiratory diseases in hospitalized COVID-19 patients. Front Immunol. 2021; 12:668074. https://doi.org/10.3389/fimmu.2021.668074
     [Google الباحث العلمي]
  52. Visos-Varela I, Zapata-Cachafeiro M, Pintos-Rodriguez S, Bugarin-Gonzalez R, Gonzalez-Barcala FJ, Herdeiro MT, et al.. Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study. J Med Virol. 2023; 95:(7):e28971. https://doi.org/10.1002/jmv.28971
     [Google الباحث العلمي]
  53. Bajči MP, Lendak DF, Ristić M, Drljača MM, Brkić S, Turkulov V, et al.. COVID-19 breakthrough infections among patients aged ≥65 years in Serbia: Morbidity and mortality overview. Vaccines. 2022; 10:(11):1818. https://doi.org/10.3390/vaccines10111818
     [Google الباحث العلمي]
  54. Carvalho VP, Pontes JPJ, Neto DRB, Borges CER, Campos GRL, Ribeiro HLS, et al.. Mortality and associated factors in patients with COVID-19: Cross-sectional study. Vaccines. 2022; 11:(1):71. https://doi.org/10.3390/vaccines11010071
     [Google الباحث العلمي]
  55. Han X, Hou H, Xu J, Ren J, Li S, Wang Y, et al.. Significant association between HIV infection and increased risk of COVID-19 mortality: A meta-analysis based on adjusted effect estimates. Clin Exp Med. 2022; 23:(3):689–700. https://doi.org/10.1007/s10238-022-00840-1
     [Google الباحث العلمي]
  56. Alhandod TA, Rabbani SI, Almuqbil M, Alshehri S, Hussain SA, Alomar NF, et al.. A systematic review on the safety and efficacy of COVID-19 vaccines approved in Saudi Arabia. Vaccines (Basel). 2023; 11:(2). https://doi.org/10.3390/vaccines11020281
     [Google الباحث العلمي]
  57. Arbel R, Pliskin J. Vaccinations versus lockdowns to prevent COVID-19 mortality. Vaccines (Basel). 2022; 10:(8). https://doi.org/10.3390/vaccines10081347
     [Google الباحث العلمي]
  58. Wang Y, Zhong H, Xie X, Chen CY, Huang D, Shen L, et al.. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci U S A. 2015; 112:(29):E3883–92. https://doi.org/10.1073/pnas.1501662112
     [Google الباحث العلمي]
  59. Li L, Robinson LB, Patel R, Landman AB, Fu X, Shenoy ES, et al.. Association of self-reported high-risk allergy history with allergy symptoms after COVID-19 vaccination. JAMA Netw Open. 2021; 4:(10):e2131034. https://doi.org/10.1001/jamanetworkopen.2021.31034
     [Google الباحث العلمي]
  60. Jaggers J, Wolfson AR. mRNA COVID-19 vaccine anaphylaxis: Epidemiology, risk factors, and evaluation. Curr Allergy Asthma Rep. 2023; 23:(3):195–200. https://doi.org/10.1007/s11882-023-01065-2
     [Google الباحث العلمي]
  61. Shavit R, Maoz-Segal R, Iancovici-Kidon M, Offengenden I, Haj Yahia S, Machnes Maayan D, et al.. Prevalence of allergic reactions after Pfizer-BioNTech COVID-19 vaccination among adults with high allergy risk. JAMA Network Open. 2021; 4:(8):e2122255. https://doi.org/10.1001/jamanetworkopen.2021.22255
     [Google الباحث العلمي]
  62. Caminati M, Guarnieri G, Batani V, Scarpieri E, Finocchiaro A, Chieco-Bianchi F, et al.. COVID-19 vaccination in patients with severe asthma on biologic treatment: Safety, tolerability, and impact on disease control. Vaccines. 2021; 9:(8):853. https://doi.org/10.3390/vaccines9080853
     [Google الباحث العلمي]
  63. Kwok WC, Leung SHI, Tam TCC, Ho JCM, Lam DC, Ip MSM, et al.. Efficacy of mRNA and inactivated whole virus vaccines against COVID-19 in patients with chronic respiratory diseases. Int J Chronic Obstruct Pulmonary Dis. 2023; 18:47–56. https://doi.org/10.2147/COPD.S394101
     [Google الباحث العلمي]
  64. Ödling M, Andersson N, EkstrÖm S, Roxhed N, Schwenk JM, BjÖrkander S, et al.. COVID-19 vaccine uptake among young adults: Influence of asthma and sociodemographic factors. J Allergy Clin Immunol Glob. 2024; 3:(2):100231. https://doi.org/10.1016/j.jacig.2024.100231
     [Google الباحث العلمي]
  65. Bossios A, Bacon AM, Eger K, Paróczai D, Schleich F, Hanon S, et al.. COVID-19 vaccination acceptance, safety and side-effects in European patients with severe asthma. ERJ Open Res. 2023; 9:(6):00590-2023. https://doi.org/10.1183/23120541.00590-2023
     [Google الباحث العلمي]
  66. Runnstrom MC, Morrison-Porter A, Ravindran M, Quehl H, Ramonell RP, Woodruff M, et al.. Reduced COVID-19 vaccine response in patients treated with biologic therapies for asthma. Am J Respir Crit Care Med. 2022; 205:(10):1243–5. https://doi.org/10.1164/rccm.202111-2496LE
     [Google الباحث العلمي]
  67. Ministerio de Sanidad. Vacuna Covid-19. https://www.sanidad.gob.es/areas/alertasEmergenciasSanitarias/alertasActuales/nCov/vacunaCovid19.htm. Accessed: March 29, 2024.
    [Google الباحث العلمي]
  68. Jackson DJ, Trujillo-Torralbo MB, del-Rosario J, Bartlett NW, Edwards MR, Mallia P, et al.. The influence of asthma control on the severity of virus-induced asthma exacerbations. J Allergy Clin Immunol. 2015; 136:(2):497–500.e3. https://doi.org/10.1016/j.jaci.2015.01.028
     [Google الباحث العلمي]
  69. Robbins E, Daoud S, Demissie S, James P. The impact of asthma on COVID-19 disease severity in children and adolescents. J Asthma. 2023; 60:(6):1097–103. https://doi.org/10.1080/02770903.2022.2132956
     [Google الباحث العلمي]
  70. Lohia P, Sreeram K, Nguyen P, Choudhary A, Khicher S, Yarandi H, et al.. Preexisting respiratory diseases and clinical outcomes in COVID-19: A multihospital cohort study on predominantly African American population. Respir Res. 2021; 22:(1):37. https://doi.org/10.1186/s12931-021-01647-6
     [Google الباحث العلمي]
  71. Gutierrez JP, Bertozzi SM. Non-communicable diseases and inequalities increase risk of death among COVID-19 patients in Mexico. PLoS One. 2020; 15:(10):e0240394. https://doi.org/10.1371/journal.pone.0240394
     [Google الباحث العلمي]
  72. Shafiee M, Aleyasin SA, Mowla SJ, Vasei M, Yazdanparast SA. The effect of microRNA-375 overexpression, an inhibitor of Helicobacter pylori-induced carcinogenesis, on lncRNA SOX2OT. Jundishapur J Microbiol. 2016; 9:(9):e23464. https://doi.org/10.5812/jjm.23464
     [Google الباحث العلمي]
  73. Global burden of chronic respiratory diseases and risk factors, 1990–2019: An update from the Global Burden of Disease Study 2019. EClinicalMedicine. 2023; 59:101936. https://doi.org/10.1016/j.eclinm.2023.101936
     [Google الباحث العلمي]
  74. Carr TF, Zeki AA, Kraft M. Eosinophilic and noneosinophilic asthma. Am J Respir Crit Care Med. 2018; 197:(1):22–37. https://doi.org/10.1164/rccm.201611-2232PP
     [Google الباحث العلمي]
  75. Kaur R, Chupp G. Phenotypes and endotypes of adult asthma: Moving toward precision medicine. J Allergy Clin Immunol. 2019; 144:(1):1–12. https://doi.org/10.1016/j.jaci.2019.05.031
     [Google الباحث العلمي]
  76. Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJ, Bel EH, et al.. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Thorax. 2015; 70:(2):115–20. https://doi.org/10.1136/thoraxjnl-2014-205634
     [Google الباحث العلمي]
  77. Rosenberg HF, Domachowske JB, et al.. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol. 2001; 70:(5):691–8.
    [Google الباحث العلمي]
  78. Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, et al.. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005; 79:(23):14614–21. https://doi.org/10.1128/JVI.79.23.14614-14621.2005
     [Google الباحث العلمي]
  79. Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS, et al.. Smoking upregulates angiotensin-converting enzyme-2 receptor: A potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19). J Clin Med. 2020; 9:(3). https://doi.org/10.3390/jcm9030841
     [Google الباحث العلمي]
  80. Jackson DJ, Busse WW, Bacharier LB, Kattan M, O’Connor GT, Wood RA, et al.. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020; 146:(1):203–6.e3. https://doi.org/10.1016/j.jaci.2020.04.009
     [Google الباحث العلمي]
  81. Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al.. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181:(2):271–80 e8. https://doi.org/10.1016/j.cell.2020.02.052
     [Google الباحث العلمي]
  82. Asarnow D, Wang B, Lee WH, Hu Y, Huang CW, Faust B, et al.. Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia. Cell. 2021; 184:(12):3192–204.e16. https://doi.org/10.1016/j.cell.2021.04.033
     [Google الباحث العلمي]
  83. Malkova A, Kudlay D, Kudryavtsev I, Starshinova A, Yablonskiy P, Shoenfeld Y. Immunogenetic predictors of severe COVID-19. Vaccines. 2021; 9:(3):211. https://doi.org/10.3390/vaccines9030211
     [Google الباحث العلمي]
  84. Khandia R, Pandey MK, Khan AA, Rzhepakovsky IV, Gurjar P, Karobari MI. Codon usage and context analysis of genes modulated during SARS-CoV-2 infection and dental inflammation. Vaccines. 2022; 10:(11):1874. https://doi.org/10.3390/vaccines10111874
     [Google الباحث العلمي]
  85. Sodhi PV, Sidime F, Tarazona DD, Valdivia F, Levano KS. A closer look at ACE2 signaling pathway and processing during COVID-19 infection: Identifying possible targets. Vaccines. 2022; 11:(1):13. https://doi.org/10.3390/vaccines11010013
     [Google الباحث العلمي]
  86. Peters MC, Sajuthi S, Deford P, Christenson S, Rios CL, Montgomery MT, et al.. COVID-19-related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids. Am J Respir Crit Care Med. 2020; 202:(1):83–90. https://doi.org/10.1164/rccm.202003-0821OC
     [Google الباحث العلمي]
  87. Chen Y, Li Y, Wang X, Zou P. Montelukast, an anti-asthmatic drug, inhibits Zika virus infection by disrupting viral integrity. Front Microbiol. 2019; 10:3079. https://doi.org/10.3389/fmicb.2019.03079
     [Google الباحث العلمي]
  88. Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, et al.. The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells. J Virol. 2020; 95:(1).
    [Google الباحث العلمي]
  89. Terry PD, Heidel RE, Dhand R. Asthma in adult patients with COVID-19. Prevalence and risk of severe disease. Am J Respir Crit Care Med. 2021; 203:893–905. https://doi.org/10.1164/rccm.202008-3266OC
     [Google الباحث العلمي]
  90. Sunjaya AP, Allida SM, Di Tanna GL, Jenkins CR. Asthma and coronavirus disease 2019 risk: A systematic review and meta-analysis. Eur Respir J. 2021; in press. https://doi.org/10.1183/13993003.01209-2021
     [Google الباحث العلمي]
  91. Hussein MH, Elshazli RM, Attia AS, Nguyen TP, Aboueisha M, Munshi R, et al.. Asthma and COVID-19; different entities, same outcome: A meta-analysis of 107,983 patients. J Asthma. 2022; 59:(5):851–8. https://doi.org/10.1080/02770903.2021.1881970
     [Google الباحث العلمي]
  92. Liu S, Cao Y, Du T, Zhi Y. Prevalence of comorbid asthma and related outcomes in COVID-19: A systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2021; 9:693–701. https://doi.org/10.1016/j.jaip.2020.11.054
     [Google الباحث العلمي]
  93. Shi L, Xu J, Xiao W, Wang Y, Jin Y, Chen S, et al.. Asthma in patients with coronavirus disease 2019: A systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2021; 126:524–34.
    [Google الباحث العلمي]
  94. Sitek AN, Ade JM, Chiarella SE, Divekar RD, Pitlick MM, Iyer VN, et al.. Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis. Allergy Asthma Proc. 2021; 42:267–73. https://doi.org/10.2500/aap.2021.42.210041
     [Google الباحث العلمي]
  95. Soeroto AY, Purwiga A, Emmy HPEHP, Roesli RMA. Asthma does not increase COVID-19 mortality and poor outcomes: A systematic review and meta-analysis. Asian Pac J Allergy Immunol. 2021. https://doi.org/10.12932/AP-110920-0955
     [Google الباحث العلمي]
  96. Wang Y, Ao G, Qi X, Xie B. The association between COVID-19 and asthma: A systematic review and meta-analysis. Clin Exp Allergy J Brit Soc Allergy Clin Immunol. 2020; 50:1274–7. https://doi.org/10.1111/cea.13733
     [Google الباحث العلمي]
  97. Hou H, Xu J, Li Y, Wang Y, Yang H. The association of asthma with COVID-19 mortality: An updated meta-analysis based on adjusted effect estimates. J Allergy Clin Immunol Pract. 2021; 9:3944–68 e5. https://doi.org/10.1016/j.jaip.2021.08.016
     [Google الباحث العلمي]
  98. Pardhan S, Wood S, Vaughan M, Trott M. The risk of COVID-19 related hospitalisation, intensive care unit admission and mortality in people with underlying asthma or COPD: A systematic review and meta-analysis. Front Med. 2021; 8:668808. https://doi.org/10.3389/fmed.2021.668808
     [Google الباحث العلمي]
  99. Wu X, Xu Y, Jin L, Wang X, Zhu H, Xie Y. Association of preexisting asthma and other allergic diseases With mortality in COVID-19 patients: A systematic review and meta-analysis. Front Med. 2021; 8:670744https://doi.org/10.3389/fmed.2021.670744
     [Google الباحث العلمي]
  100. Wang Y, Chen J, Chen W, Liu L, Dong M, Ji J, et al.. Does asthma increase the mortality of patients with COVID-19? A systematic review and meta-analysis. Int Arch Allergy Immunol. 2021; 182:76–82. https://doi.org/10.1159/000510953
     [Google الباحث العلمي]
  101. Reyes FM, Hache-Marliere M, Karamanis D, Berto CG, Estrada R, Langston M, et al.. Assessment of the association of COPD and asthma with in-hospital mortality in patients with COVID-19. A systematic review, meta-analysis, and meta-regression analysis. J Clin Med. 2021;10. https://doi.org/10.3390/jcm10102087
     [Google الباحث العلمي]
/content/journals/10.5339/qmj.2024.34
Loading
Significant association between asthma and a lower risk of mortality among COVID-19 patients in Spain: A meta-analysis
Qatar Medical Journal 2024, 34 (٢٠٢٤); https://doi.org/10.5339/qmj.2024.34
/content/journals/10.5339/qmj.2024.34
/content/journals/10.5339/qmj.2024.34
Loading

جارٍ تحميل البيانات والوسائط...

  • نوع المستند: Review Article
الموضوعات الرئيسية asthma, coronavirus disease 2019, meta-analysis, Mortality, severe acute respiratory syndrome coronavirus 2 and Spain

الأكثر اقتباسًا لهذا الشهر Most Cited RSS feed

هذه الخانة مطلوبة
يُرجى إدخال عنوان بريد إلكتروني صالح
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error